Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Purchased by XTX Topco Ltd

XTX Topco Ltd lifted its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 312.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,033 shares of the company's stock after buying an additional 14,420 shares during the quarter. XTX Topco Ltd's holdings in Ryan Specialty were worth $1,221,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Mariner LLC raised its position in Ryan Specialty by 3.4% during the fourth quarter. Mariner LLC now owns 5,278 shares of the company's stock worth $339,000 after acquiring an additional 172 shares during the last quarter. Barclays PLC raised its position in shares of Ryan Specialty by 3.0% during the 4th quarter. Barclays PLC now owns 1,690,279 shares of the company's stock worth $108,449,000 after purchasing an additional 48,536 shares during the last quarter. Summit Investment Advisors Inc. lifted its stake in Ryan Specialty by 1.5% in the 4th quarter. Summit Investment Advisors Inc. now owns 21,311 shares of the company's stock valued at $1,367,000 after buying an additional 323 shares in the last quarter. Synovus Financial Corp lifted its stake in Ryan Specialty by 1.6% in the 4th quarter. Synovus Financial Corp now owns 50,594 shares of the company's stock valued at $3,246,000 after buying an additional 804 shares in the last quarter. Finally, Grandeur Peak Global Advisors LLC acquired a new stake in Ryan Specialty during the 4th quarter valued at $4,231,000. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Nicholas Dominic Cortezi sold 10,485 shares of the business's stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $65.12, for a total transaction of $682,783.20. Following the transaction, the director now directly owns 11,109 shares in the company, valued at approximately $723,418.08. The trade was a 48.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 141,894 shares of company stock valued at $9,429,470. Company insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

RYAN has been the topic of several recent research reports. Royal Bank of Canada reduced their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. Keefe, Bruyette & Woods decreased their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. TD Cowen initiated coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They set a "buy" rating and a $89.00 price target for the company. Wells Fargo & Company reduced their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Finally, Barclays lowered their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, Ryan Specialty has an average rating of "Hold" and a consensus target price of $75.67.

Ryan Specialty Trading Down 2.0 %

Ryan Specialty stock traded down $1.46 during midday trading on Friday, reaching $70.63. The stock had a trading volume of 967,494 shares, compared to its average volume of 945,518. The stock has a market capitalization of $18.50 billion, a PE ratio of 102.37, a price-to-earnings-growth ratio of 1.19 and a beta of 0.66. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The stock's 50-day simple moving average is $70.46 and its 200 day simple moving average is $69.02. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $663.53 million for the quarter, compared to analysts' expectations of $658.80 million. Analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were given a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 4th. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is presently 69.57%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.